COMMUNIQUÉS West-GlobeNewswire

Precision Optics Corporation, Inc. Raises $2 million in Private Placement
18/10/2018
GARDNER, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that it has sold an aggregate of 1,600,000 shares of its common stock at a price of $1. [...]
B. Braun Space Infusion Pump Systems Compatible with Allscripts Sunrise
18/10/2018
BETHLEHEM, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today it has completed the bi-directional integration testing with Allscripts Sunrise™ electronic health record (EHR). The completion of [...]
CTD Holdings Posts Recording of its Webinar on US Clinical Trial
18/10/2018
Webinar recording is on the Company website ALACHUA, Fla., Oct. 18, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the [...]
Retrophin to Report Third Quarter 2018 Financial Results
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report third quarter 2018 financial results on Thursday, November 1, 2018 after the close of the U.S. financial markets [...]
Harvard Bioscience Schedules Third Quarter 2018 Conference Call for October 25 at 4:30 PM ET
18/10/2018
HOLLISTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for [...]
Sarepta Therapeutics to Announce Third Quarter 2018 Financial Results and Recent Corporate Developments on October 24, 2018
18/10/2018
CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, will report third quarter 2018 financial results after the Nasdaq [...]
Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine
18/10/2018
Combines Neon’s Personal Neoantigen Vaccine and Signatera (RUO) Circulating Tumor DNA Biomarker in Metastatic Non-Small Cell Lung Cancer Trial SAN CARLOS, Calif. and CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- [...]
TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018
18/10/2018
WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO) will announce third-quarter 2018 financial results on Thursday, November 1, 2018, after the close of the U.S. financial markets. TESARO’s [...]
Intuitive Surgical Announces Third Quarter Earnings
18/10/2018
SUNNYVALE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), a global technology leader in robotic-assisted, minimally invasive surgery, today announced financial results [...]
Helius Medical Technologies to Release Third Quarter 2018 Financial Results on November 8, 2018
18/10/2018
NEWTOWN, Pa., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that third [...]
IRIDEX to Report Third Quarter 2018 Financial Results on November 1, 2018
18/10/2018
MOUNTAIN VIEW, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter 2018 after the close of trading on Thursday, [...]
NewLink Genetics to Host Its Third Quarter 2018 Financial Results Conference Call on November 1, 2018
18/10/2018
AMES, Iowa, Oct. 18, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will release its third quarter 2018 financial results on Thursday, November 1, 2018. The company has [...]
La Jolla Pharmaceutical Company to Release Third Quarter 2018 Financial Results on October 24, 2018
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Cytokinetics to Announce Third Quarter Results on November 1, 2018
18/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report third quarter results on November 1, 2018 at 4:00 PM Eastern Time. [...]
Engineered Cymerus™ MSCs Demonstrate Anti-Cancer Effects in Preclinical Studies
18/10/2018
Positive results in preclinical models support the use of the Cymerus platform to target various cancers MELBOURNE, Australia, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical stage [...]
Akorn Appeals Fresenius Kabi Ruling
18/10/2018
LAKE FOREST, Ill., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that the company filed a notice of appeal to the Supreme Court of the [...]
Sensorion Reports Pipeline Update and First-Half-Year 2018 Results; Re-design of SENS-111 Study
18/10/2018
Three active Phase 2 programs for inner ear diseases now extend the scope of the clinical pipeline Strategic research partnerships with world-leading research institutes and industry leaders (Cochlear) strengthen domain [...]
Who is Focused on the Huge Opportunity in Medical Cannabis? -- CFN Media
18/10/2018
SEATTLE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Syapse Hosts Inaugural Precision Medicine Council to Drive Progress in Precision Oncology
18/10/2018
Nation’s leading health systems convene today to share best practices and improve cancer care SAN FRANCISCO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Syapse, the leading precision medicine company, is convening innovative [...]

Pages